GGrantIndex
← Leaderboards

Kathlynn C Brown

University Of Texas Sw Med Ctr/Dallas

$5,380,612
Attributed
$6,050,679
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $711.8K · FY200516
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$6,050,679 · 5

By mechanism

R01$5,742,345 · 4
R21$308,334 · 1

Top collaborators

Most similar at University Of Texas Sw Med Ctr/Dallas

Same institution · by research overlap

Others in their field

Top investigators on “Affinity

Research focus

AffinityCell SurfaceTranslatingIn VivoCellsDrug Delivery SystemsPeptidesIn VitroSpecificityTumorMalignant Neoplasm Of LungLaboratoriesLigandsMalignant NeoplasmsAnimal ModelDiagnosisBinding (Molecular Function)Biological MarkersCell TypeLung NeoplasmsPharmaceutical PreparationsCancer DiagnosisCancer Cell LineCancer Cell

Grant awards (21)

A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer$409,070
R01 · FY2016 · CA · contact PI
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer$409,191
R01 · FY2015 · CA · contact PI
Multi-Layered Valency: A Novel Design of Peptidic Imaging Agents for αvβ6$298,103
R01 · FY2015 · EB · contact PI
Multi-Layered Valency: A Novel Design of Peptidic Imaging Agents for ??v??6$347,017
R01 · FY2014 · EB · contact PI
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer$248,800
R01 · FY2014 · CA · contact PI
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer$115,937
R01 · FY2014 · CA · contact PI
Multi-Layered Valency: A Novel Design of Peptidic Imaging Agents for ??v??6$337,358
R01 · FY2013 · EB · contact PI
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer$310,130
R01 · FY2013 · CA · contact PI
Multi-Layered Valency: A Novel Design of Peptidic Imaging Agents for ??v??6$357,657
R01 · FY2012 · EB · contact PI
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer$313,615
R01 · FY2012 · CA · contact PI
Diagnostic & targeting reagents for lung cancer$322,453
R01 · FY2008 · CA · contact PI
Diagnostic & targeting reagents for lung cancer$64,364
R01 · FY2008 · CA · contact PI
Diagnostic & targeting reagents for lung cancer$317,464
R01 · FY2007 · CA · contact PI
Diagnostic & targeting reagents for lung cancer$49,843
R01 · FY2007 · CA · contact PI
Diagnostic & targeting reagents for lung cancer$325,742
R01 · FY2006 · CA · contact PI
A High Throughput Diagnostic Assay for Lung Cancer$152,334
R21 · FY2006 · CA · contact PI
Diagnostic &targeting reagents for lung cancer$363,241
R01 · FY2005 · CA
A High Throughput Diagnostic Assay for Lung Cancer$156,000
R21 · FY2005 · CA
Chemical &Biological Approaches for Cell Targeting$390,000
R01 · FY2004 · AI
Chemical &Biological Approaches for Cell Targeting$390,000
R01 · FY2003 · AI
Chemical &Biological Approaches for Cell Targeting$372,360
R01 · FY2002 · AI